lenalidomide stada 5 mg cietās kapsulas
stada arzneimittel ag, germany - lenalidomīds - kapsula, cietā - 5 mg
lenalidomide stada 15 mg cietās kapsulas
stada arzneimittel ag, germany - lenalidomīds - kapsula, cietā - 15 mg
carmustine medac (previously carmustine obvius)
medac gesellschaft für klinische spezialpräparate mbh - karmustīns - hodgkin disease; lymphoma, non-hodgkin - antineoplastiski līdzekļi - carmustine is indicated n adults in the following malignant neoplasms as a single agent or in combination with other antineoplastic agents and/or other therapeutic measures (radiotherapy, surgery): , brain tumours (glioblastoma, brain-stem gliomas, medulloblastoma, astrocytoma and ependymoma), brain metastases, secondary therapy in non-hodgkin’s lymphoma and hodgkin’s disease, as conditioning treatment prior to autologous haematopoietic progenitor cell transplantation (hpct) in malignant haematological diseases (hodgkin’s disease / non-hodgkin’s lymphoma).
lenalidomide norameda 25 mg cietās kapsulas
norameda uab, lithuania - lenalidomīds - kapsula, cietā - 25 mg
lenalidomide sandoz 2,5 mg cietās kapsulas
sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 2,5 mg
lenalidomide sandoz 5 mg cietās kapsulas
sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 5 mg
lenalidomide sandoz 10 mg cietās kapsulas
sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 10 mg
lenalidomide sandoz 15 mg cietās kapsulas
sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 15 mg
lenalidomide sandoz 25 mg cietās kapsulas
sandoz d.d., slovenia - lenalidomīds - kapsula, cietā - 25 mg
lenalidomide teva 25 mg cietās kapsulas
teva b.v., netherlands - lenalidomīds - kapsula, cietā - 25 mg